Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
MicroPort CardioFlow Medtech Corporation, a medical device company, researches, develops, and commercializes transcatheter and surgical solutions for structural heart diseases in the People's Republic of China. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set to target aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is overpriced on P/E.
Target Price
The average target price of 2160.HK is 1.8 and suggests 38% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d
Buy
Sell